Stealth Therapeutics' Unattributed - III Round

Stealth Therapeutics raised a round of funding on August 10, 2017.

Stealth Therapeutics was founded in January 2006 for the purpose of designing and developing a portfolio of improved venous access devices (VADs). The Invisiport is the first micro-invasive implantabl…

Articles about Stealth Therapeutics' Unattributed - III Round: